Importance of tyrosine phosphorylation in angiotensin II type 1 receptor signaling

Hypertension

Volumn 27, Issue 3 II, 1996, Pages 476-480

  Schieffer, Bernhard ^a   Paxton, William G ^a   Marrero, Mario B ^a,b   Bernstein, Kenneth E ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

phospholipase C 1; protein tyrosine kinase; protein tyrosine phosphatase; receptor, angiotensin II; signal transduction

Indexed keywords

ANGIOTENSIN RECEPTOR; PHOSPHOLIPASE C; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE PHOSPHATASE;

CONFERENCE PAPER; HUMAN; HYPERTENSION; PHOSPHORYLATION; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SIGNAL TRANSDUCTION;

EID: 0029917332     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.hyp.27.3.476     Document Type: Conference Paper

References (51)

1. c-src in platelet-activating factor-stimulated platelets: evidence for translocation from cytosol to membrane. J Biol Chem. 1991;266:18797-18801.
2. Granot Y, Van Putten V, Schrier RW. Vasopressin dependent tyrosine phosphorylation of a 38 kDa protein in human platelets. Biochem Biophys Res Commun. 1990;168:566-573.
3. Guinebault C, Payrastre B, Sultan C, Mauco G, Breton M, Levy-Tolenado S, Plantavid M, Chap H. Tyrosine kinases and phosphoinositide metabolism in thrombin stimulated human platelets. Biochem J. 1993;292:851-856.
4. 2+ dependently stimulates protein tyrosine phosphorylation in BC3H1 cells. Biochem J. 1993;290:27-32.
5. Tate BF, Rittenhouse SE. Thrombin activation of human platelets causes tyrosine phosphorylation of PLC-γ1. Biochim Biophys Acta. 1993;1178:281-285.
6. Wilkes LC, Patel V, Purkiss JR, Boarder MR. Endothelin-1 stimulated phospholipase D in A10 vascular smooth muscle derived cells is dependent on tyrosine kinase: evidence for involvement in stimulation of mitogenesis. FEBS Lett. 1993;322:147-150.
7. Chock PB, Stadtman ER. Superiority of interconvertible enzyme cascades in metabolite regulation: analysis of metacyclic systems. Proc Natl Acad Sci U S A. 1977;74:2766-2770.
8. Van Der Geer, Hunter T, Lindberg RA. Receptor protein tyrosine kinases and their signal transduction. Annu Rev Cell Biol. 1994;10: 251-338.
9. Barford D. Molecular mechanisms for the control of enzymatic activity by protein phosphorylation. Biochim Biophys Acta. 1991; 1133:55-62.
10. Daemen MJ, Lombardi DM, Bosman FT, Schwartz SM. Angiotensin II induces smooth muscle cell proliferation in the normal and injured rat arterial wall. Circ Res. 1991;68:450-456.
11. Geisterfer AA, Peach MJ, Owens GK. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ Res. 1988;62:749-756.
12. Naftilan AJ, Pratt RE, Dzau VJ. Induction of platelet-derived growth factor A-chain and c-myc gene expression by angiotensin II in cultured rat vascular smooth muscle cells. J Clin Invest. 1989;83: 1419-1424.
13. Gibbons GH, Pratt RE, Dzau VJ. Vascular smooth muscle cell hypertrophy versus hyperplasia: autocrine transforming growth factor-beta 1 expression determines growth response to angiotensin II. J Clin Invest. 1992;90:456-461.
14. Weber H, Taylor DS, Molloy CJ. Angiotensin II induces delayed mitogenesis and cellular proliferation in rat aortic smooth muscle cells: correlation with the expression of specific growth factors and reversal by suramin. J Clin Invest. 1994;93:788-798.
15. Powell JS, Clozel JP, Muller RKM, Kuhn H, Hefti F, Hosang M, Baumgartner HR. Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science. 1989;245:186-188.
16. Schieffer B, Wirger A, Meybrunn M, Seitz S, Holtz J, Riede UN, Drexler H. Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction. Circulation 1994; 89:2273-2282.
17. Owens GK, Schwartz SM. Alterations in smooth muscle cell mass in spontaneously hypertensive rats: role of cellular hypertrophy, hyperploidy and hyperplasia. Circ Res. 1982;51:280-289.
18. Stouffer GA, Owens GK. Angiotensin II-induced mitogenesis of spontaneously hypertensive rat-derived cultured smooth muscle cells is dependent on autocrine production of transforming growth factor-beta. Circ Res. 1982;70:820-828.
19. Murphy TJ, Alexander RW, Griendling KK, Runge MS, Bernstein KE. Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature. 1991;351:233-236.
20. Sasaki K, Yamano Y, Bardham S, Iwai N, Murray JJ, Hasegawa M, Matsuda Y, Inagami T. Cloning and expression of a complementary DNA encoding a bovine adrenal angiotensin II receptor. Nature 1991;351:230-233.
21. Timmermans PB, Wong PC, Chiu AT, Herblin WF. Nonpeptide angiotensin II receptor antagonists. Trends Pharmacol Sci 1991;12: 55-62.
22. Timmermans PB, Wong PC, Chiu AT, Herblin WF, Benfield P, Carini DJ, Lee RJ, Wexler RR, Saye JM, Smith RD. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev 1993;45:205-251.
23. Gottlieb SS, Dickstein K, Fleck E, Kostis J, Levine TB, LeJemtel T, DeKock M. Hemodynamic and neurohormonal effects of the angiotensin II antagonist losartan in patients with congestive heart failure. Circulation. 1993;88:1602-1609.
24. Sweet CS, Rucinska EJ. Losartan in heart failure: preclinical experiences and initial clinical outcomes. Eur Heart J. 1994;15(suppl D):139-144.
25. Dolhman HG, Caron MG, Lefkowitz RJ. A family of receptors coupled to guanine nucleotide regulatory proteins. Biochemistry. 1987;26:2657-2664.
26. Griendling KK, Lassegue B, Murphy TJ, Alexander RW. Angiotensin II receptor pharmacology. Adv Pharmacol. 1994;28:269-306.
27. Pouyssegur J. G proteins in growth factor action. In: Birnbaumer L, Iyengar R, eds. G-Proteins. Orlando, Fla: Academic Press; 1990: 555-570.
28. 1 receptor subtype. Circ Res. 1993;73:413-423.
29. Sadoshima J, Izumo S. Signal transduction pathways of angiotensin II-induced c-fos gene expression in cardiac myocytes in vitro: roles in phospholipid-derived second messengers. Circ Res. 1993;73: 424-438.
30. Alexander RW, Brock TA, Gimbrone MA, Rittenhouse SL. Angiotensin II increases inositol triphosphate and calcium in vascular smooth muscle cells. Hypertension. 1985;7:447-451.
31. Berridge MJ. Inositol triphosphate and diacylglycerol: two interacting second messengers. Annu Rev Biochem. 1987;56:159-193.
32. Cockcroft S, Thomas GMH. Inositol-lipid-specific phospholipase C isoenzymes and their differential regulation by receptors. Biochem J. 1992;288:1-14.
33. Marrero MB, Paxton WG, Duff JL, Berk BC, Bernstein KE. Angiotensin II stimulates tyrosine phosphorylation of phospholipase C-γ1 in vascular smooth muscle cells. J Biol Chem. 1994;269: 10935-10939.
34. Force T, Kyriakis JM, Aruch J, Bonventre JV. Endothelin, vasopressin, and angiotensin II enhance tyrosine phosphorylation by protein kinase C-dependent and -independent pathways in glomerular mesangial cells. J Biol Chem. 1991;266:6650-6656.
35. - channels in glomerular mesangial cells. Am J Physiol. In press.
36. Marrero MB, Schieffer B, Bernstein KE, Ling BN. Angiotensin II-induced, tyrosine phosphorylation in mesangial and vascular smooth muscle cells. Exp Pharm Physiol. In press.
37. Tsuda T, Kawahara Y, Shii K, Koide M, Ishida Y, Yokoyama M. Vasoconstrictor induced protein-tyrosine phosphorylation in cultured rat vascular smooth muscle cells. FEBS Lett. 1991;285:44-48.
38. Molloy CJ, Taylor DS, Weber H. Angiotensin II stimulation of rapid tyrosine phosphorylation and protein kinase activation in rat aortic smooth muscle cells. J Biol Chem. 1993;268:7338-7345.
39. 1 receptor is tyrosine and serine phosphorylated and can serve as a substrate for the src family of tyrosine kinases. Biochem Biophys Res Commun. 1994;200:260-267.
40. Liao F, Shin HS, Rhee SG. In vitro tyrosine phosphorylation of phospholipase C-γ1 and phospholipase C-γ2 by src-family protein tyrosine kinase. Biochem Biophys Res Commun. 1993;191:1028-1033.
41. c-src monoclonal antibody inhibits activation of phospholipase C in platelets. J Biol Chem. 1994;269:9123-9127.
42. c-src antibodies inhibits the angiotensin II activation of phospholipase-γ1 in rat aortic smooth muscle cells. J Biol Chem. 1995;270:15734-15738.
43. c-src in vascular smooth muscle cells. Circ Res. 1995;77: 1053-1059.
44. 1A receptor activates transcription factor stat91 and/or a related protein. J Biol Chem. 1994;269: 31443-31449.
45. Schorb W, Peeler TC, Madigan NN, Conrad KM, Baker KM. Angiotensin II-induced tyrosine phosphorylation in neonatal rat cardiac fibroblasts. J Biol Chem. 1994;269:19626-19632.
46. 1 receptor. Nature. 1995;375:247-250.
47. Taubman MB, Berk BC, Izumo S, Tsuda T, Alexander RW, Nadal-Ginard B. Angiotensin II induces c-fos mRNA in aortic muscle cells. J Biol Chem. 1989;264:526-530.
48. Duff JL, Marrero MB, Paxton WG, Schieffer B, Bernstein KE, Berk BC. Angiotensin II signal transduction and the mitogen activated protein kinase pathway. Cardiovasc Res. 1995;30:511-517.
49. Schindler C, Darnell JE Jr. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. Annu Rev Biochem. 1995;64:621-651.
50. Darnell JE Jr, Kerr IM, Stark GR. JAK-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science. 1994;264:1415-1421.
51. Rodriguez-Linares B, Watson SP. Phosphorylation of JAK2 in thrombin-stimulated human platelets. FEBS Lett. 1994;352: 335-338.